ACXP Acurx Pharmaceuticals, Inc.

4d ago, source: Seeking Alpha

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company’s lead antibiotic candidate is ibezapolstat, a novel ...

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript

1mon ago, source: InvestingChannel on MSN

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript March 18, 2024 Acurx Pharmaceuticals, Inc. isn't ...

Acurx Pharmaceuticals LLC

5mon ago, source: CNN

Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens.

Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV

1mon ago, source: Business Insider

Staten Island, New York--(Newsfile Corp. - March 21, 2024) - Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the ...

Acurx Pharmaceuticals Inc Ordinary Shares

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

3mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Acurx Pharmaceuticals: Strong Buy on Ibezapolstat’s Promising Phase 3 Trials and Strategic Partnerships

1mon ago, source: Business Insider

H.C. Wainwright analyst Ed Arce maintained a Buy rating on Acurx Pharmaceuticals (ACXP – Research Report) today and set a price target of $12.00. Ed Arce has given his Buy rating due to a ...

Acurx Pharmaceuticals Rings the Closing Bell

9d ago, source: Nasdaq

Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, visits the ...

ACXP Acurx Pharmaceuticals, Inc.

6mon ago, source: Seeking Alpha

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company’s lead antibiotic candidate is ibezapolstat, a novel ...

Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV

1mon ago, source: Yahoo Finance

Acurx Pharmaceuticals, Inc. is scheduled to present on April 8th at 2:30 pm ET. David P. Luci will be leading the presentation. We invite interested parties to register to watch the presentation ...

Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV

1mon ago, source: Stockhouse

Staten Island, New York--(Newsfile Corp. - March 21, 2024) - Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the ...